Characterization of angiotensin receptors in vascular and intestinal smooth muscles
Open Access
- 1 June 1973
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 48 (2) , 288-301
- https://doi.org/10.1111/j.1476-5381.1973.tb06915.x
Abstract
1 . A series of analogues of angiotensin II (ATII) has been used in the present experiments to characterize receptors for ATII in intestinal (rat stomach strip, rat colon) and vascular (rabbit aorta) smooth muscles. Two types of compounds have been chosen: (a) agonists with reduced potency, in which 4-Tyr, 6-His or 7-Pro had been substituted with l-Ala or with Gly and 1-aminocyclopentane carboxylic acid (Acpc) and (b) competitive antagonists (8-Gly-ATII, 8-Leu-ATII). 2 . Replacement of 4-Tyr, 6-His and 7-Pro with l-Ala decreases the potency, but does not influence the maximum effect of the analogue, while substitution of the same residue with Gly and Acpc reduces both potency and maximum effect. 3 . Compounds showing full size maximum responses were chosen to establish the following order of potency on the three preparations: ATII>4-Phe-ATII> 7-Ala-ATII>6-Ala-ATII>4-Ala-ATII. 4 . The four derivatives of ATII were completely inactive on tissues desensitized with ATII. The responses to 5-hydroxytryptamine, acetylcholine and noradrenaline were not significantly modified, except for the rat colon. 5 . pA2 values for the two competitive antagonists against ATII and 4-Phe-ATII were estimated in the three preparations by the use of the cascade superfusion technique. For comparison, pA2 values were also estimated in rat stomach strips and rabbit aortas suspended in a normal organ bath, according to the method of Schild (1947). The similarities of the pA2 values obtained in two series of experiments indicate that (a) the cascade superfusion technique is suitable for this type of study and (b) the receptor for ATII in the three tissues may be the same. 6 . It is suggested that receptors for ATII in intestinal and vascular smooth muscles may be the same, because (a) the order of potency of various agonists follows the same pattern, (b) the agonists are inactive on tissues desensitized with ATII, (c) pA2 values for competitive antagonists are similar in the three preparations.Keywords
This publication has 20 references indexed in Scilit:
- II. Pharmacology of Angiotensin AntagonistsCanadian Journal of Physiology and Pharmacology, 1973
- I. Pharmacology of Angiotensin AntagonistsCanadian Journal of Physiology and Pharmacology, 1973
- The Pressor and Myotropic Effects and the Antagonistic Properties of Several Analogues of Angiotensin IICanadian Journal of Physiology and Pharmacology, 1972
- A Specific Competitive Antagonist of the Vascular Action of Angiotensin IICirculation Research, 1971
- Competitive antagonism of 8-ala-angiotensin II to angiotensins I and II on isolated rabbit aorta and rat ascending colonEuropean Journal of Pharmacology, 1971
- Analogs of angiotensin II. II. Mechanism of receptor interactionJournal of Medicinal Chemistry, 1970
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963
- Synthesis of Alanyl-isoleucyl-angiotensin IIJournal of the American Chemical Society, 1962
- Synthesis of Isoleucyl5-alanyl7-angiotensin IIJournal of the American Chemical Society, 1962
- Zur Synthese von N‐t‐Butyloxycarbonyl‐aminosäurenHelvetica Chimica Acta, 1959